Author:
KUBANOVA A A,LESNAYA I N,FRIGO N V,KAGANOVA N L,ZNAMENSKAYA L F,KUBANOV A A
Abstract
Biosamples (skin tissue samples taken from affection foci and blood serum) from 22 patients suffering from severe to medium psoriasis (8 women and 14 men) aged 19-57 treated with Infliximab were analyzed. As for skin tissue samples, the molecular structure of genes TNF-a, TNF-R-I and TNF-R-II, contents of cytokine TNF-a and its soluble receptors (sTNF-RI and sTNF-RII) and proteome composition was analyzed in skin tissue samples; contents of TNF-a, IL2, IL4, IL6, IL-8 and IL-10 were analyzed in the blood serum. The homozygous TT genotype of TNF-R-II gene at the 676 locus and high IL10 level in the blood serum (>2.7 pg/ml) was associated with the high intensity of the psoriasis patient response to treatment with Infliximab; the homozygous GG genotype of TNF-R-II gene at the 676 locus and low level of IL10 in the blood serum (
Publisher
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov
Reference32 articles.
1. Гинтер Е.А. Эволюция представлений о генетической природе мультифакториальных заболеваний. // Медицинская генетика. 2003. Т. 2. № 4. С. 146-156.
2. Campalani E., Barker J. The clinical genetics of psoriasis. // Current Genomics. 2005. V. 6. P. 51-60.
3. Скрипкин Ю.К., Мордовцев В.Н. Кожные и венерические болезни: Руководство для врачей. - М: Медицина, 1999. С. 116-118.
4. Mease P. TNF-alpha therapy in psoriatic arthritis and psoriasis. // Ann. Rheum. Dis. 2004. Jul. N. 63(7). P. 755-8.
5. Zhang M., Tracey K.J. Tumor necrosis factor. In: Thompson A.W. // In: The cytokine handbook, 3rd ed. New York. Academic press. 1998. 515-548.